Global Platinum-based Antineoplastic Production, Demand and Key Producers, 2022-2028
A kind of chemotherapy medication
This report studies the global Platinum-based Antineoplastic production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Platinum-based Antineoplastic, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Platinum-based Antineoplastic that contribute to its increasing demand across many markets.
The global Platinum-based Antineoplastic market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Platinum-based Antineoplastic total production and demand, 2017-2028, (Units)
Global Platinum-based Antineoplastic total production value, 2017-2028, (USD Million)
Global Platinum-based Antineoplastic production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Units)
Global Platinum-based Antineoplastic consumption by region & country, CAGR, 2017-2028 & (Units)
U.S. VS China: Platinum-based Antineoplastic domestic production, consumption, key domestic manufacturers and share
Global Platinum-based Antineoplastic production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Units)
Global Platinum-based Antineoplastic production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Units)
Global Platinum-based Antineoplastic production by Application production, value, CAGR, 2017-2028, (USD Million) & (Units)
This reports profiles key players in the global Platinum-based Antineoplastic market based on the following parameters – headquarters, production locations, products portfolio, Platinum-based Antineoplastic revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Platinum-based Antineoplastic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Platinum-based Antineoplastic Market, By Region:
1. How big is the global Platinum-based Antineoplastic market?
2. What is the demand of the global Platinum-based Antineoplastic market?
3. What is the year over year growth of the global Platinum-based Antineoplastic market?
4. What is the production and production value of the global Platinum-based Antineoplastic market?
5. Who are the key producers in the global Platinum-based Antineoplastic market?
6. What are the growth factors driving the market demand?
This report studies the global Platinum-based Antineoplastic production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Platinum-based Antineoplastic, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Platinum-based Antineoplastic that contribute to its increasing demand across many markets.
The global Platinum-based Antineoplastic market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Platinum-based Antineoplastic total production and demand, 2017-2028, (Units)
Global Platinum-based Antineoplastic total production value, 2017-2028, (USD Million)
Global Platinum-based Antineoplastic production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Units)
Global Platinum-based Antineoplastic consumption by region & country, CAGR, 2017-2028 & (Units)
U.S. VS China: Platinum-based Antineoplastic domestic production, consumption, key domestic manufacturers and share
Global Platinum-based Antineoplastic production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Units)
Global Platinum-based Antineoplastic production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Units)
Global Platinum-based Antineoplastic production by Application production, value, CAGR, 2017-2028, (USD Million) & (Units)
This reports profiles key players in the global Platinum-based Antineoplastic market based on the following parameters – headquarters, production locations, products portfolio, Platinum-based Antineoplastic revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Platinum-based Antineoplastic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Platinum-based Antineoplastic Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Cisplatin
- Carboplatin
- Nedaplatin
- Oxaliplatin
- Lobaplatin
- Cycloplatin
- Combination Therapy
- Monotherapy
- Targeted Therapy
- Pfizer
- AstraZeneca
- Roche
- Sanofi
- Bristol-Myers Squibb
- Asta Medica GmbH
- Simcere Pharmaceutical
- Abbvie
- Novartis
- GSK
- MSD
- Hengrui Medicine
- Hansoh Pharmaceutical Group
- ChiTaiTianQing Pharmaceutical Group
- CSPC Pharmaceutical Group
1. How big is the global Platinum-based Antineoplastic market?
2. What is the demand of the global Platinum-based Antineoplastic market?
3. What is the year over year growth of the global Platinum-based Antineoplastic market?
4. What is the production and production value of the global Platinum-based Antineoplastic market?
5. Who are the key producers in the global Platinum-based Antineoplastic market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Platinum-based Antineoplastic Introduction
1.2 World Platinum-based Antineoplastic Supply & Forecast
1.2.1 World Platinum-based Antineoplastic Production Value (2017 & 2021 & 2028)
1.2.2 World Platinum-based Antineoplastic Production (2017-2028)
1.2.3 World Platinum-based Antineoplastic Pricing Trends (2017-2028)
1.3 World Platinum-based Antineoplastic Production by Region
1.3.1 World Platinum-based Antineoplastic Production Value by Region (2017-2028)
1.3.2 World Platinum-based Antineoplastic Production by Region (2017-2028)
1.3.3 World Platinum-based Antineoplastic Average Price by Region (2017-2028)
1.3.4 North America Platinum-based Antineoplastic Production (2017-2028)
1.3.5 Europe Platinum-based Antineoplastic Production (2017-2028)
1.3.6 China Platinum-based Antineoplastic Production (2017-2028)
1.3.7 Japan Platinum-based Antineoplastic Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Platinum-based Antineoplastic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Platinum-based Antineoplastic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Platinum-based Antineoplastic Demand (2017-2028)
2.2 World Platinum-based Antineoplastic Consumption by Region
2.2.1 World Platinum-based Antineoplastic Consumption by Region (2017-2022)
2.2.2 World Platinum-based Antineoplastic Consumption Forecast by Region (2023-2028)
2.3 United States Platinum-based Antineoplastic Consumption (2017-2028)
2.4 China Platinum-based Antineoplastic Consumption (2017-2028)
2.5 Europe Platinum-based Antineoplastic Consumption (2017-2028)
2.6 Japan Platinum-based Antineoplastic Consumption (2017-2028)
2.7 South Korea Platinum-based Antineoplastic Consumption (2017-2028)
2.8 ASEAN Platinum-based Antineoplastic Consumption (2017-2028)
2.9 India Platinum-based Antineoplastic Consumption (2017-2028)
3 WORLD PLATINUM-BASED ANTINEOPLASTIC MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Platinum-based Antineoplastic Production Value by Manufacturer (2017-2022)
3.2 World Platinum-based Antineoplastic Production by Manufacturer (2017-2022)
3.3 World Platinum-based Antineoplastic Average Price by Manufacturer (2017-2022)
3.4 Platinum-based Antineoplastic Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Platinum-based Antineoplastic Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Platinum-based Antineoplastic in 2021
3.5.3 Global Concentration Ratios (CR8) for Platinum-based Antineoplastic in 2021
3.6 Platinum-based Antineoplastic Market: Overall Company Footprint Analysis
3.6.1 Platinum-based Antineoplastic Market: Region Footprint
3.6.2 Platinum-based Antineoplastic Market: Company Product Type Footprint
3.6.3 Platinum-based Antineoplastic Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Platinum-based Antineoplastic Production Value Comparison
4.1.1 United States VS China: Platinum-based Antineoplastic Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Platinum-based Antineoplastic Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Platinum-based Antineoplastic Production Comparison
4.2.1 United States VS China: Platinum-based Antineoplastic Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Platinum-based Antineoplastic Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Platinum-based Antineoplastic Consumption Comparison
4.3.1 United States VS China: Platinum-based Antineoplastic Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Platinum-based Antineoplastic Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Platinum-based Antineoplastic Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Platinum-based Antineoplastic in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022)
4.5 China Platinum-based Antineoplastic Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Platinum-based Antineoplastic in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Platinum-based Antineoplastic Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Platinum-based Antineoplastic in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Platinum-based Antineoplastic Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Cisplatin
5.2.2 Carboplatin
5.2.3 Nedaplatin
5.2.4 Oxaliplatin
5.2.5 Lobaplatin
5.2.6 Cycloplatin
5.3 Market Segment by Type
5.3.1 World Platinum-based Antineoplastic Production by Type (2017-2028)
5.3.2 World Platinum-based Antineoplastic Production Value by Type (2017-2028)
5.3.3 World Platinum-based Antineoplastic Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Platinum-based Antineoplastic Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Combination Therapy
6.2.2 Monotherapy
6.2.3 Targeted Therapy
6.3 Market Segment by Application
6.3.1 World Platinum-based Antineoplastic Production by Application (2017-2028)
6.3.2 World Platinum-based Antineoplastic Production Value by Application (2017-2028)
6.3.3 World Platinum-based Antineoplastic Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Platinum-based Antineoplastic Product and Services
7.1.4 Pfizer Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Platinum-based Antineoplastic Product and Services
7.2.4 AstraZeneca Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche Platinum-based Antineoplastic Product and Services
7.3.4 Roche Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Platinum-based Antineoplastic Product and Services
7.4.4 Sanofi Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Details
7.5.2 Bristol-Myers Squibb Major Business
7.5.3 Bristol-Myers Squibb Platinum-based Antineoplastic Product and Services
7.5.4 Bristol-Myers Squibb Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Bristol-Myers Squibb Recent Developments/Updates
7.5.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.6 Asta Medica GmbH
7.6.1 Asta Medica GmbH Details
7.6.2 Asta Medica GmbH Major Business
7.6.3 Asta Medica GmbH Platinum-based Antineoplastic Product and Services
7.6.4 Asta Medica GmbH Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Asta Medica GmbH Recent Developments/Updates
7.6.6 Asta Medica GmbH Competitive Strengths & Weaknesses
7.7 Simcere Pharmaceutical
7.7.1 Simcere Pharmaceutical Details
7.7.2 Simcere Pharmaceutical Major Business
7.7.3 Simcere Pharmaceutical Platinum-based Antineoplastic Product and Services
7.7.4 Simcere Pharmaceutical Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Simcere Pharmaceutical Recent Developments/Updates
7.7.6 Simcere Pharmaceutical Competitive Strengths & Weaknesses
7.8 Abbvie
7.8.1 Abbvie Details
7.8.2 Abbvie Major Business
7.8.3 Abbvie Platinum-based Antineoplastic Product and Services
7.8.4 Abbvie Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Abbvie Recent Developments/Updates
7.8.6 Abbvie Competitive Strengths & Weaknesses
7.9 Novartis
7.9.1 Novartis Details
7.9.2 Novartis Major Business
7.9.3 Novartis Platinum-based Antineoplastic Product and Services
7.9.4 Novartis Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Novartis Recent Developments/Updates
7.9.6 Novartis Competitive Strengths & Weaknesses
7.10 GSK
7.10.1 GSK Details
7.10.2 GSK Major Business
7.10.3 GSK Platinum-based Antineoplastic Product and Services
7.10.4 GSK Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 GSK Recent Developments/Updates
7.10.6 GSK Competitive Strengths & Weaknesses
7.11 MSD
7.11.1 MSD Details
7.11.2 MSD Major Business
7.11.3 MSD Platinum-based Antineoplastic Product and Services
7.11.4 MSD Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 MSD Recent Developments/Updates
7.11.6 MSD Competitive Strengths & Weaknesses
7.12 Hengrui Medicine
7.12.1 Hengrui Medicine Details
7.12.2 Hengrui Medicine Major Business
7.12.3 Hengrui Medicine Platinum-based Antineoplastic Product and Services
7.12.4 Hengrui Medicine Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Hengrui Medicine Recent Developments/Updates
7.12.6 Hengrui Medicine Competitive Strengths & Weaknesses
7.13 Hansoh Pharmaceutical Group
7.13.1 Hansoh Pharmaceutical Group Details
7.13.2 Hansoh Pharmaceutical Group Major Business
7.13.3 Hansoh Pharmaceutical Group Platinum-based Antineoplastic Product and Services
7.13.4 Hansoh Pharmaceutical Group Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Hansoh Pharmaceutical Group Recent Developments/Updates
7.13.6 Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
7.14 ChiTaiTianQing Pharmaceutical Group
7.14.1 ChiTaiTianQing Pharmaceutical Group Details
7.14.2 ChiTaiTianQing Pharmaceutical Group Major Business
7.14.3 ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Product and Services
7.14.4 ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 ChiTaiTianQing Pharmaceutical Group Recent Developments/Updates
7.14.6 ChiTaiTianQing Pharmaceutical Group Competitive Strengths & Weaknesses
7.15 CSPC Pharmaceutical Group
7.15.1 CSPC Pharmaceutical Group Details
7.15.2 CSPC Pharmaceutical Group Major Business
7.15.3 CSPC Pharmaceutical Group Platinum-based Antineoplastic Product and Services
7.15.4 CSPC Pharmaceutical Group Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 CSPC Pharmaceutical Group Recent Developments/Updates
7.15.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Platinum-based Antineoplastic and Key Manufacturers
8.2 Platinum-based Antineoplastic Manufacturing Costs
8.3 Platinum-based Antineoplastic Production Process
8.4 Platinum-based Antineoplastic Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Platinum-based Antineoplastic Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Platinum-based Antineoplastic Typical Distributors
9.3 Platinum-based Antineoplastic Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Platinum-based Antineoplastic Introduction
1.2 World Platinum-based Antineoplastic Supply & Forecast
1.2.1 World Platinum-based Antineoplastic Production Value (2017 & 2021 & 2028)
1.2.2 World Platinum-based Antineoplastic Production (2017-2028)
1.2.3 World Platinum-based Antineoplastic Pricing Trends (2017-2028)
1.3 World Platinum-based Antineoplastic Production by Region
1.3.1 World Platinum-based Antineoplastic Production Value by Region (2017-2028)
1.3.2 World Platinum-based Antineoplastic Production by Region (2017-2028)
1.3.3 World Platinum-based Antineoplastic Average Price by Region (2017-2028)
1.3.4 North America Platinum-based Antineoplastic Production (2017-2028)
1.3.5 Europe Platinum-based Antineoplastic Production (2017-2028)
1.3.6 China Platinum-based Antineoplastic Production (2017-2028)
1.3.7 Japan Platinum-based Antineoplastic Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Platinum-based Antineoplastic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Platinum-based Antineoplastic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Platinum-based Antineoplastic Demand (2017-2028)
2.2 World Platinum-based Antineoplastic Consumption by Region
2.2.1 World Platinum-based Antineoplastic Consumption by Region (2017-2022)
2.2.2 World Platinum-based Antineoplastic Consumption Forecast by Region (2023-2028)
2.3 United States Platinum-based Antineoplastic Consumption (2017-2028)
2.4 China Platinum-based Antineoplastic Consumption (2017-2028)
2.5 Europe Platinum-based Antineoplastic Consumption (2017-2028)
2.6 Japan Platinum-based Antineoplastic Consumption (2017-2028)
2.7 South Korea Platinum-based Antineoplastic Consumption (2017-2028)
2.8 ASEAN Platinum-based Antineoplastic Consumption (2017-2028)
2.9 India Platinum-based Antineoplastic Consumption (2017-2028)
3 WORLD PLATINUM-BASED ANTINEOPLASTIC MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Platinum-based Antineoplastic Production Value by Manufacturer (2017-2022)
3.2 World Platinum-based Antineoplastic Production by Manufacturer (2017-2022)
3.3 World Platinum-based Antineoplastic Average Price by Manufacturer (2017-2022)
3.4 Platinum-based Antineoplastic Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Platinum-based Antineoplastic Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Platinum-based Antineoplastic in 2021
3.5.3 Global Concentration Ratios (CR8) for Platinum-based Antineoplastic in 2021
3.6 Platinum-based Antineoplastic Market: Overall Company Footprint Analysis
3.6.1 Platinum-based Antineoplastic Market: Region Footprint
3.6.2 Platinum-based Antineoplastic Market: Company Product Type Footprint
3.6.3 Platinum-based Antineoplastic Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Platinum-based Antineoplastic Production Value Comparison
4.1.1 United States VS China: Platinum-based Antineoplastic Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Platinum-based Antineoplastic Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Platinum-based Antineoplastic Production Comparison
4.2.1 United States VS China: Platinum-based Antineoplastic Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Platinum-based Antineoplastic Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Platinum-based Antineoplastic Consumption Comparison
4.3.1 United States VS China: Platinum-based Antineoplastic Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Platinum-based Antineoplastic Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Platinum-based Antineoplastic Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Platinum-based Antineoplastic in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022)
4.5 China Platinum-based Antineoplastic Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Platinum-based Antineoplastic in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Platinum-based Antineoplastic Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Platinum-based Antineoplastic in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Platinum-based Antineoplastic Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Cisplatin
5.2.2 Carboplatin
5.2.3 Nedaplatin
5.2.4 Oxaliplatin
5.2.5 Lobaplatin
5.2.6 Cycloplatin
5.3 Market Segment by Type
5.3.1 World Platinum-based Antineoplastic Production by Type (2017-2028)
5.3.2 World Platinum-based Antineoplastic Production Value by Type (2017-2028)
5.3.3 World Platinum-based Antineoplastic Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Platinum-based Antineoplastic Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Combination Therapy
6.2.2 Monotherapy
6.2.3 Targeted Therapy
6.3 Market Segment by Application
6.3.1 World Platinum-based Antineoplastic Production by Application (2017-2028)
6.3.2 World Platinum-based Antineoplastic Production Value by Application (2017-2028)
6.3.3 World Platinum-based Antineoplastic Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Platinum-based Antineoplastic Product and Services
7.1.4 Pfizer Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Platinum-based Antineoplastic Product and Services
7.2.4 AstraZeneca Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche Platinum-based Antineoplastic Product and Services
7.3.4 Roche Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Platinum-based Antineoplastic Product and Services
7.4.4 Sanofi Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Details
7.5.2 Bristol-Myers Squibb Major Business
7.5.3 Bristol-Myers Squibb Platinum-based Antineoplastic Product and Services
7.5.4 Bristol-Myers Squibb Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Bristol-Myers Squibb Recent Developments/Updates
7.5.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.6 Asta Medica GmbH
7.6.1 Asta Medica GmbH Details
7.6.2 Asta Medica GmbH Major Business
7.6.3 Asta Medica GmbH Platinum-based Antineoplastic Product and Services
7.6.4 Asta Medica GmbH Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Asta Medica GmbH Recent Developments/Updates
7.6.6 Asta Medica GmbH Competitive Strengths & Weaknesses
7.7 Simcere Pharmaceutical
7.7.1 Simcere Pharmaceutical Details
7.7.2 Simcere Pharmaceutical Major Business
7.7.3 Simcere Pharmaceutical Platinum-based Antineoplastic Product and Services
7.7.4 Simcere Pharmaceutical Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Simcere Pharmaceutical Recent Developments/Updates
7.7.6 Simcere Pharmaceutical Competitive Strengths & Weaknesses
7.8 Abbvie
7.8.1 Abbvie Details
7.8.2 Abbvie Major Business
7.8.3 Abbvie Platinum-based Antineoplastic Product and Services
7.8.4 Abbvie Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Abbvie Recent Developments/Updates
7.8.6 Abbvie Competitive Strengths & Weaknesses
7.9 Novartis
7.9.1 Novartis Details
7.9.2 Novartis Major Business
7.9.3 Novartis Platinum-based Antineoplastic Product and Services
7.9.4 Novartis Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Novartis Recent Developments/Updates
7.9.6 Novartis Competitive Strengths & Weaknesses
7.10 GSK
7.10.1 GSK Details
7.10.2 GSK Major Business
7.10.3 GSK Platinum-based Antineoplastic Product and Services
7.10.4 GSK Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 GSK Recent Developments/Updates
7.10.6 GSK Competitive Strengths & Weaknesses
7.11 MSD
7.11.1 MSD Details
7.11.2 MSD Major Business
7.11.3 MSD Platinum-based Antineoplastic Product and Services
7.11.4 MSD Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 MSD Recent Developments/Updates
7.11.6 MSD Competitive Strengths & Weaknesses
7.12 Hengrui Medicine
7.12.1 Hengrui Medicine Details
7.12.2 Hengrui Medicine Major Business
7.12.3 Hengrui Medicine Platinum-based Antineoplastic Product and Services
7.12.4 Hengrui Medicine Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Hengrui Medicine Recent Developments/Updates
7.12.6 Hengrui Medicine Competitive Strengths & Weaknesses
7.13 Hansoh Pharmaceutical Group
7.13.1 Hansoh Pharmaceutical Group Details
7.13.2 Hansoh Pharmaceutical Group Major Business
7.13.3 Hansoh Pharmaceutical Group Platinum-based Antineoplastic Product and Services
7.13.4 Hansoh Pharmaceutical Group Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Hansoh Pharmaceutical Group Recent Developments/Updates
7.13.6 Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
7.14 ChiTaiTianQing Pharmaceutical Group
7.14.1 ChiTaiTianQing Pharmaceutical Group Details
7.14.2 ChiTaiTianQing Pharmaceutical Group Major Business
7.14.3 ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Product and Services
7.14.4 ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 ChiTaiTianQing Pharmaceutical Group Recent Developments/Updates
7.14.6 ChiTaiTianQing Pharmaceutical Group Competitive Strengths & Weaknesses
7.15 CSPC Pharmaceutical Group
7.15.1 CSPC Pharmaceutical Group Details
7.15.2 CSPC Pharmaceutical Group Major Business
7.15.3 CSPC Pharmaceutical Group Platinum-based Antineoplastic Product and Services
7.15.4 CSPC Pharmaceutical Group Platinum-based Antineoplastic Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 CSPC Pharmaceutical Group Recent Developments/Updates
7.15.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Platinum-based Antineoplastic and Key Manufacturers
8.2 Platinum-based Antineoplastic Manufacturing Costs
8.3 Platinum-based Antineoplastic Production Process
8.4 Platinum-based Antineoplastic Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Platinum-based Antineoplastic Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Platinum-based Antineoplastic Typical Distributors
9.3 Platinum-based Antineoplastic Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Platinum-based Antineoplastic Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Platinum-based Antineoplastic Production Value by Region (2017-2022) & (USD Million)
Table 3. World Platinum-based Antineoplastic Production Value by Region (2023-2028) & (USD Million)
Table 4. World Platinum-based Antineoplastic Production Value Market Share by Region (2017-2022)
Table 5. World Platinum-based Antineoplastic Production Value Market Share by Region (2023-2028)
Table 6. World Platinum-based Antineoplastic Production by Region (2017-2022) & (Units)
Table 7. World Platinum-based Antineoplastic Production by Region (2023-2028) & (Units)
Table 8. World Platinum-based Antineoplastic Production Market Share by Region (2017-2022)
Table 9. World Platinum-based Antineoplastic Production Market Share by Region (2023-2028)
Table 10. World Platinum-based Antineoplastic Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Platinum-based Antineoplastic Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Platinum-based Antineoplastic Major Market Trends
Table 13. World Platinum-based Antineoplastic Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Units)
Table 14. World Platinum-based Antineoplastic Consumption by Region (2017-2022) & (Units)
Table 15. World Platinum-based Antineoplastic Consumption Forecast by Region (2023-2028) & (Units)
Table 16. World Platinum-based Antineoplastic Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Platinum-based Antineoplastic Producers in 2021
Table 18. World Platinum-based Antineoplastic Production by Manufacturer (2017-2022) & (Units)
Table 19. Production Market Share of Key Platinum-based Antineoplastic Producers in 2021
Table 20. World Platinum-based Antineoplastic Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Platinum-based Antineoplastic Company Evaluation Quadrant
Table 22. World Platinum-based Antineoplastic Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Platinum-based Antineoplastic Production Site of Key Manufacturer
Table 24. Platinum-based Antineoplastic Market: Company Product Type Footprint
Table 25. Platinum-based Antineoplastic Market: Company Product Application Footprint
Table 26. Platinum-based Antineoplastic Competitive Factors
Table 27. Platinum-based Antineoplastic New Entrant and Capacity Expansion Plans
Table 28. Platinum-based Antineoplastic Mergers & Acquisitions Activity
Table 29. United States VS China Platinum-based Antineoplastic Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Platinum-based Antineoplastic Production Comparison, (2017 & 2021 & 2028) & (Units)
Table 31. United States VS China Platinum-based Antineoplastic Consumption Comparison, (2017 & 2021 & 2028) & (Units)
Table 32. Major Manufacturer of Platinum-based Antineoplastic in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Platinum-based Antineoplastic Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 36. United States Platinum-based Antineoplastic Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Platinum-based Antineoplastic in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Platinum-based Antineoplastic Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 41. China Platinum-based Antineoplastic Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Platinum-based Antineoplastic in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Platinum-based Antineoplastic Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 46. Rest of World Platinum-based Antineoplastic Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Platinum-based Antineoplastic Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Platinum-based Antineoplastic Production by Type (2017-2022) & (Units)
Table 49. World Platinum-based Antineoplastic Production by Type (2023-2028) & (Units)
Table 50. World Platinum-based Antineoplastic Production Value by Type (2017-2022) & (USD Million)
Table 51. World Platinum-based Antineoplastic Production Value by Type (2023-2028) & (USD Million)
Table 52. World Platinum-based Antineoplastic Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Platinum-based Antineoplastic Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Platinum-based Antineoplastic Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Platinum-based Antineoplastic Production by Application (2017-2022) & (Units)
Table 56. World Platinum-based Antineoplastic Production by Application (2023-2028) & (Units)
Table 57. World Platinum-based Antineoplastic Production Value by Application (2017-2022) & (USD Million)
Table 58. World Platinum-based Antineoplastic Production Value by Application (2023-2028) & (USD Million)
Table 59. World Platinum-based Antineoplastic Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Platinum-based Antineoplastic Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Platinum-based Antineoplastic Product and Services
Table 64. Pfizer Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Platinum-based Antineoplastic Product and Services
Table 70. AstraZeneca Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche Platinum-based Antineoplastic Product and Services
Table 76. Roche Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Roche Recent Developments/Updates
Table 78. Roche Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Platinum-based Antineoplastic Product and Services
Table 82. Sanofi Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 86. Bristol-Myers Squibb Major Business
Table 87. Bristol-Myers Squibb Platinum-based Antineoplastic Product and Services
Table 88. Bristol-Myers Squibb Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 91. Asta Medica GmbH Basic Information, Manufacturing Base and Competitors
Table 92. Asta Medica GmbH Major Business
Table 93. Asta Medica GmbH Platinum-based Antineoplastic Product and Services
Table 94. Asta Medica GmbH Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Asta Medica GmbH Recent Developments/Updates
Table 96. Asta Medica GmbH Competitive Strengths & Weaknesses
Table 97. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Simcere Pharmaceutical Major Business
Table 99. Simcere Pharmaceutical Platinum-based Antineoplastic Product and Services
Table 100. Simcere Pharmaceutical Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Simcere Pharmaceutical Recent Developments/Updates
Table 102. Simcere Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Abbvie Basic Information, Manufacturing Base and Competitors
Table 104. Abbvie Major Business
Table 105. Abbvie Platinum-based Antineoplastic Product and Services
Table 106. Abbvie Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Abbvie Recent Developments/Updates
Table 108. Abbvie Competitive Strengths & Weaknesses
Table 109. Novartis Basic Information, Manufacturing Base and Competitors
Table 110. Novartis Major Business
Table 111. Novartis Platinum-based Antineoplastic Product and Services
Table 112. Novartis Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Novartis Recent Developments/Updates
Table 114. Novartis Competitive Strengths & Weaknesses
Table 115. GSK Basic Information, Manufacturing Base and Competitors
Table 116. GSK Major Business
Table 117. GSK Platinum-based Antineoplastic Product and Services
Table 118. GSK Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. GSK Recent Developments/Updates
Table 120. GSK Competitive Strengths & Weaknesses
Table 121. MSD Basic Information, Manufacturing Base and Competitors
Table 122. MSD Major Business
Table 123. MSD Platinum-based Antineoplastic Product and Services
Table 124. MSD Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. MSD Recent Developments/Updates
Table 126. MSD Competitive Strengths & Weaknesses
Table 127. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 128. Hengrui Medicine Major Business
Table 129. Hengrui Medicine Platinum-based Antineoplastic Product and Services
Table 130. Hengrui Medicine Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Hengrui Medicine Recent Developments/Updates
Table 132. Hengrui Medicine Competitive Strengths & Weaknesses
Table 133. Hansoh Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 134. Hansoh Pharmaceutical Group Major Business
Table 135. Hansoh Pharmaceutical Group Platinum-based Antineoplastic Product and Services
Table 136. Hansoh Pharmaceutical Group Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Hansoh Pharmaceutical Group Recent Developments/Updates
Table 138. Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
Table 139. ChiTaiTianQing Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 140. ChiTaiTianQing Pharmaceutical Group Major Business
Table 141. ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Product and Services
Table 142. ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. ChiTaiTianQing Pharmaceutical Group Recent Developments/Updates
Table 144. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 145. CSPC Pharmaceutical Group Major Business
Table 146. CSPC Pharmaceutical Group Platinum-based Antineoplastic Product and Services
Table 147. CSPC Pharmaceutical Group Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Platinum-based Antineoplastic Raw Material
Table 149. Key Manufacturers of Platinum-based Antineoplastic Raw Materials
Table 150. Platinum-based Antineoplastic Typical Distributors
Table 151. Platinum-based Antineoplastic Typical Customers
Table 1. World Platinum-based Antineoplastic Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Platinum-based Antineoplastic Production Value by Region (2017-2022) & (USD Million)
Table 3. World Platinum-based Antineoplastic Production Value by Region (2023-2028) & (USD Million)
Table 4. World Platinum-based Antineoplastic Production Value Market Share by Region (2017-2022)
Table 5. World Platinum-based Antineoplastic Production Value Market Share by Region (2023-2028)
Table 6. World Platinum-based Antineoplastic Production by Region (2017-2022) & (Units)
Table 7. World Platinum-based Antineoplastic Production by Region (2023-2028) & (Units)
Table 8. World Platinum-based Antineoplastic Production Market Share by Region (2017-2022)
Table 9. World Platinum-based Antineoplastic Production Market Share by Region (2023-2028)
Table 10. World Platinum-based Antineoplastic Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Platinum-based Antineoplastic Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Platinum-based Antineoplastic Major Market Trends
Table 13. World Platinum-based Antineoplastic Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Units)
Table 14. World Platinum-based Antineoplastic Consumption by Region (2017-2022) & (Units)
Table 15. World Platinum-based Antineoplastic Consumption Forecast by Region (2023-2028) & (Units)
Table 16. World Platinum-based Antineoplastic Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Platinum-based Antineoplastic Producers in 2021
Table 18. World Platinum-based Antineoplastic Production by Manufacturer (2017-2022) & (Units)
Table 19. Production Market Share of Key Platinum-based Antineoplastic Producers in 2021
Table 20. World Platinum-based Antineoplastic Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Platinum-based Antineoplastic Company Evaluation Quadrant
Table 22. World Platinum-based Antineoplastic Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Platinum-based Antineoplastic Production Site of Key Manufacturer
Table 24. Platinum-based Antineoplastic Market: Company Product Type Footprint
Table 25. Platinum-based Antineoplastic Market: Company Product Application Footprint
Table 26. Platinum-based Antineoplastic Competitive Factors
Table 27. Platinum-based Antineoplastic New Entrant and Capacity Expansion Plans
Table 28. Platinum-based Antineoplastic Mergers & Acquisitions Activity
Table 29. United States VS China Platinum-based Antineoplastic Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Platinum-based Antineoplastic Production Comparison, (2017 & 2021 & 2028) & (Units)
Table 31. United States VS China Platinum-based Antineoplastic Consumption Comparison, (2017 & 2021 & 2028) & (Units)
Table 32. Major Manufacturer of Platinum-based Antineoplastic in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Platinum-based Antineoplastic Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 36. United States Platinum-based Antineoplastic Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Platinum-based Antineoplastic in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Platinum-based Antineoplastic Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 41. China Platinum-based Antineoplastic Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Platinum-based Antineoplastic in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Platinum-based Antineoplastic Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Platinum-based Antineoplastic Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Platinum-based Antineoplastic Production by Domestic Manufacturer, (2017-2022) & (Units)
Table 46. Rest of World Platinum-based Antineoplastic Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Platinum-based Antineoplastic Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Platinum-based Antineoplastic Production by Type (2017-2022) & (Units)
Table 49. World Platinum-based Antineoplastic Production by Type (2023-2028) & (Units)
Table 50. World Platinum-based Antineoplastic Production Value by Type (2017-2022) & (USD Million)
Table 51. World Platinum-based Antineoplastic Production Value by Type (2023-2028) & (USD Million)
Table 52. World Platinum-based Antineoplastic Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Platinum-based Antineoplastic Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Platinum-based Antineoplastic Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Platinum-based Antineoplastic Production by Application (2017-2022) & (Units)
Table 56. World Platinum-based Antineoplastic Production by Application (2023-2028) & (Units)
Table 57. World Platinum-based Antineoplastic Production Value by Application (2017-2022) & (USD Million)
Table 58. World Platinum-based Antineoplastic Production Value by Application (2023-2028) & (USD Million)
Table 59. World Platinum-based Antineoplastic Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Platinum-based Antineoplastic Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Platinum-based Antineoplastic Product and Services
Table 64. Pfizer Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Platinum-based Antineoplastic Product and Services
Table 70. AstraZeneca Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche Platinum-based Antineoplastic Product and Services
Table 76. Roche Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Roche Recent Developments/Updates
Table 78. Roche Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Platinum-based Antineoplastic Product and Services
Table 82. Sanofi Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 86. Bristol-Myers Squibb Major Business
Table 87. Bristol-Myers Squibb Platinum-based Antineoplastic Product and Services
Table 88. Bristol-Myers Squibb Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 91. Asta Medica GmbH Basic Information, Manufacturing Base and Competitors
Table 92. Asta Medica GmbH Major Business
Table 93. Asta Medica GmbH Platinum-based Antineoplastic Product and Services
Table 94. Asta Medica GmbH Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Asta Medica GmbH Recent Developments/Updates
Table 96. Asta Medica GmbH Competitive Strengths & Weaknesses
Table 97. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Simcere Pharmaceutical Major Business
Table 99. Simcere Pharmaceutical Platinum-based Antineoplastic Product and Services
Table 100. Simcere Pharmaceutical Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Simcere Pharmaceutical Recent Developments/Updates
Table 102. Simcere Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Abbvie Basic Information, Manufacturing Base and Competitors
Table 104. Abbvie Major Business
Table 105. Abbvie Platinum-based Antineoplastic Product and Services
Table 106. Abbvie Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Abbvie Recent Developments/Updates
Table 108. Abbvie Competitive Strengths & Weaknesses
Table 109. Novartis Basic Information, Manufacturing Base and Competitors
Table 110. Novartis Major Business
Table 111. Novartis Platinum-based Antineoplastic Product and Services
Table 112. Novartis Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Novartis Recent Developments/Updates
Table 114. Novartis Competitive Strengths & Weaknesses
Table 115. GSK Basic Information, Manufacturing Base and Competitors
Table 116. GSK Major Business
Table 117. GSK Platinum-based Antineoplastic Product and Services
Table 118. GSK Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. GSK Recent Developments/Updates
Table 120. GSK Competitive Strengths & Weaknesses
Table 121. MSD Basic Information, Manufacturing Base and Competitors
Table 122. MSD Major Business
Table 123. MSD Platinum-based Antineoplastic Product and Services
Table 124. MSD Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. MSD Recent Developments/Updates
Table 126. MSD Competitive Strengths & Weaknesses
Table 127. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 128. Hengrui Medicine Major Business
Table 129. Hengrui Medicine Platinum-based Antineoplastic Product and Services
Table 130. Hengrui Medicine Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Hengrui Medicine Recent Developments/Updates
Table 132. Hengrui Medicine Competitive Strengths & Weaknesses
Table 133. Hansoh Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 134. Hansoh Pharmaceutical Group Major Business
Table 135. Hansoh Pharmaceutical Group Platinum-based Antineoplastic Product and Services
Table 136. Hansoh Pharmaceutical Group Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Hansoh Pharmaceutical Group Recent Developments/Updates
Table 138. Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
Table 139. ChiTaiTianQing Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 140. ChiTaiTianQing Pharmaceutical Group Major Business
Table 141. ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Product and Services
Table 142. ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. ChiTaiTianQing Pharmaceutical Group Recent Developments/Updates
Table 144. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 145. CSPC Pharmaceutical Group Major Business
Table 146. CSPC Pharmaceutical Group Platinum-based Antineoplastic Product and Services
Table 147. CSPC Pharmaceutical Group Platinum-based Antineoplastic Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Platinum-based Antineoplastic Raw Material
Table 149. Key Manufacturers of Platinum-based Antineoplastic Raw Materials
Table 150. Platinum-based Antineoplastic Typical Distributors
Table 151. Platinum-based Antineoplastic Typical Customers
LIST OF FIGURES
Figure 1. Platinum-based Antineoplastic Picture
Figure 2. World Platinum-based Antineoplastic Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Platinum-based Antineoplastic Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 5. World Platinum-based Antineoplastic Average Price (2017-2028) & (US$/Unit)
Figure 6. World Platinum-based Antineoplastic Production Value Market Share by Region (2017-2028)
Figure 7. World Platinum-based Antineoplastic Production Market Share by Region (2017-2028)
Figure 8. North America Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 9. Europe Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 10. China Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 11. Japan Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 12. Platinum-based Antineoplastic Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Platinum-based Antineoplastic Demand (2017-2028) & (Units)
Figure 15. World Platinum-based Antineoplastic Consumption Market Share by Region (2017-2028)
Figure 16. United States Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 17. China Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 18. Europe Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 19. Japan Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 20. South Korea Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 21. ASEAN Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 22. India Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 23. Producer Shipments of Platinum-based Antineoplastic by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Platinum-based Antineoplastic Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Platinum-based Antineoplastic Markets in 2021
Figure 26. United States VS China: Platinum-based Antineoplastic Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Platinum-based Antineoplastic Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Platinum-based Antineoplastic Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Platinum-based Antineoplastic in United States
Figure 30. Key Producers and Market Share of Platinum-based Antineoplastic in China
Figure 31. Key Producers and Market Share of Platinum-based Antineoplastic in Rest of World
Figure 32. World Platinum-based Antineoplastic Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Platinum-based Antineoplastic Production Value Market Share by Type in 2021
Figure 34. Cisplatin
Figure 35. Carboplatin
Figure 36. Nedaplatin
Figure 37. Oxaliplatin
Figure 38. Lobaplatin
Figure 39. Cycloplatin
Figure 40. World Platinum-based Antineoplastic Production Market Share by Type (2017-2028)
Figure 41. World Platinum-based Antineoplastic Production Value Market Share by Type (2017-2028)
Figure 42. World Platinum-based Antineoplastic Average Price by Type (2017-2028) & (US$/Unit)
Figure 43. World Platinum-based Antineoplastic Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 44. World Platinum-based Antineoplastic Production Value Market Share by Application in 2021
Figure 45. Combination Therapy
Figure 46. Monotherapy
Figure 47. Targeted Therapy
Figure 48. World Platinum-based Antineoplastic Production Market Share by Application (2017-2028)
Figure 49. World Platinum-based Antineoplastic Production Value Market Share by Application (2017-2028)
Figure 50. World Platinum-based Antineoplastic Average Price by Application (2017-2028) & (US$/Unit)
Figure 51. Manufacturing Cost Structure Analysis of Platinum-based Antineoplastic in 2021
Figure 52. Manufacturing Process Analysis of Platinum-based Antineoplastic
Figure 53. Platinum-based Antineoplastic Industrial Chain
Figure 54. Distribution Channel Breakdown for Platinum-based Antineoplastic Shipments (%): 2017-2028
Figure 55. Direct Channel Pros & Cons
Figure 56. Indirect Channel Pros & Cons
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Platinum-based Antineoplastic Picture
Figure 2. World Platinum-based Antineoplastic Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Platinum-based Antineoplastic Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 5. World Platinum-based Antineoplastic Average Price (2017-2028) & (US$/Unit)
Figure 6. World Platinum-based Antineoplastic Production Value Market Share by Region (2017-2028)
Figure 7. World Platinum-based Antineoplastic Production Market Share by Region (2017-2028)
Figure 8. North America Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 9. Europe Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 10. China Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 11. Japan Platinum-based Antineoplastic Production (2017-2028) & (Units)
Figure 12. Platinum-based Antineoplastic Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Platinum-based Antineoplastic Demand (2017-2028) & (Units)
Figure 15. World Platinum-based Antineoplastic Consumption Market Share by Region (2017-2028)
Figure 16. United States Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 17. China Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 18. Europe Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 19. Japan Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 20. South Korea Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 21. ASEAN Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 22. India Platinum-based Antineoplastic Consumption (2017-2028) & (Units)
Figure 23. Producer Shipments of Platinum-based Antineoplastic by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Platinum-based Antineoplastic Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Platinum-based Antineoplastic Markets in 2021
Figure 26. United States VS China: Platinum-based Antineoplastic Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Platinum-based Antineoplastic Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Platinum-based Antineoplastic Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Platinum-based Antineoplastic in United States
Figure 30. Key Producers and Market Share of Platinum-based Antineoplastic in China
Figure 31. Key Producers and Market Share of Platinum-based Antineoplastic in Rest of World
Figure 32. World Platinum-based Antineoplastic Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Platinum-based Antineoplastic Production Value Market Share by Type in 2021
Figure 34. Cisplatin
Figure 35. Carboplatin
Figure 36. Nedaplatin
Figure 37. Oxaliplatin
Figure 38. Lobaplatin
Figure 39. Cycloplatin
Figure 40. World Platinum-based Antineoplastic Production Market Share by Type (2017-2028)
Figure 41. World Platinum-based Antineoplastic Production Value Market Share by Type (2017-2028)
Figure 42. World Platinum-based Antineoplastic Average Price by Type (2017-2028) & (US$/Unit)
Figure 43. World Platinum-based Antineoplastic Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 44. World Platinum-based Antineoplastic Production Value Market Share by Application in 2021
Figure 45. Combination Therapy
Figure 46. Monotherapy
Figure 47. Targeted Therapy
Figure 48. World Platinum-based Antineoplastic Production Market Share by Application (2017-2028)
Figure 49. World Platinum-based Antineoplastic Production Value Market Share by Application (2017-2028)
Figure 50. World Platinum-based Antineoplastic Average Price by Application (2017-2028) & (US$/Unit)
Figure 51. Manufacturing Cost Structure Analysis of Platinum-based Antineoplastic in 2021
Figure 52. Manufacturing Process Analysis of Platinum-based Antineoplastic
Figure 53. Platinum-based Antineoplastic Industrial Chain
Figure 54. Distribution Channel Breakdown for Platinum-based Antineoplastic Shipments (%): 2017-2028
Figure 55. Direct Channel Pros & Cons
Figure 56. Indirect Channel Pros & Cons
Figure 57. Methodology
Figure 58. Research Process and Data Source
